SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with Lumentums fixed exchange ratio tying its deal value to Marvells share price. Traders are debating the deals value as LITE falls alongside MRVL, questioning whether the headline premium holds up as the acquirers stock weakens.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells agreement to acquire Lumentum in an all-stock deal is the dominant focus, with traders concerned about shareholder dilution, financing, and integration risks as the stock sells off. Others see strategic value in combining Marvells AI-connectivity business with Lumentums optical technology, but debate how long the benefits may take to materialize.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Buzz centers on reports that a POET optical engine appeared in Foxconns photonics ecosystem at Hon Hai Tech Day, which bulls view as validation of the FIT collaboration and POETs AI data-center optics opportunity. The display has not confirmed production orders or scaled shipments, leaving traders divided between optimism about commercialization and frustration over the lack of concrete customer updates ahead of earnings.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes third-quarter results beat expectations, with strong revenue growth led by Auvelity and a narrower-than-expected loss. Traders welcomed the report and see cash-flow break-even approaching, while the lack of formal guidance drew some concern.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals European Lithium acquisition is driving attention, with traders weighing greater ownership of Tanbreez and added assets against dilution and potential selling pressure from newly issued shares. High reported short interest and borrowing costs have fueled squeeze speculation, though the community is divided over whether the deal is ultimately bullish or a near-term overhang.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

CIFRs quarterly results are driving discussion, with traders criticizing weak revenue and ongoing cash-generation and financing concerns despite reported progress bringing HPC leases into service. The reaction is split between fears that debt and the miner-to-AI infrastructure transition will weigh on the stock and bullish arguments that contracted leases and continued AI demand support the longer-term case.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AIs Q3 results and higher full-year revenue guidance are driving discussion, with traders noting the reported EPS beat and asking whether the company is finally GAAP-positive. Despite the upbeat report, shares are lower, fueling debate over a sell-the-news reaction versus improving fundamentals.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to fresh 52-week highs has drawn attention as traders focus on the upcoming Q3 report and BRIUMVIs commercial momentum. Buyout and short-squeeze theories are also prominent, but remain speculation; some traders attribute the move to earnings positioning and momentum instead.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment has focused attention on potential competition for Precigens PAPZIMEOS and prompted concern about its market position. Traders debate whether the rivals treatment regimen will pressure PAPZIMEOS or whether Precigens commercial head start, payer access, and full-approval status will help it retain an advantage.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

LEU is drawing attention amid a steep, volatile selloff, with traders blaming the recent stock-and-warrant offering and potential dilution, while also debating high valuation and the cost and timeline of expanding enrichment capacity. Bulls point to DOE support, customer contracts and centrifuge production progress as reasons the long-term domestic nuclear-fuel opportunity remains intact, while others expect continued pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CF Industries (CF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CF (CF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Intrepid Potash Selected for $139M USDA Grant for SOP Project

IPI secures selection for $139M in USDA funding to build a 220,000-ton SOP facility, aiming to diversify its fertilizer portfolio and drive long-term growth.

Intrepid Potash (IPI) Reports Next Week: Wall Street Expects Earnings Growth

Intrepid Potash (IPI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Intrepid Selected for USDA Matching Grant Award to Support Carlsbad Sulfate of Potash Project

Intrepid Potash, Inc. (Intrepid or the Company) (NYSE:IPI), a leading diversified mineral company serving the agriculture and animal feed markets, and the only U.S. producer of muriate of potash, today announced that the U.S. Department of Agriculture (USDA) selected Intrepids sulfate of potash...

Intrepid Announces Date for Third Quarter 2026 Earnings Release

Intrepid Potash, Inc. (NYSE: IPI) plans to release its third quarter 2026 financial results on Tuesday, November 3, 2026, after the market closes. Intrepid will host a conference call on Wednesday, November 4, 2026, at 12:00 p.m. Eastern Time to discuss the results, outlook, and other operating and...

Zacks Industry Outlook Highlights Nutrien, ICL and Intrepid Potash

Fertilizer prices are rising despite industry headwinds, creating growth opportunities for Nutrien, ICL Group and Intrepid Potash.

3 Fertilizer Stocks to Keep an Eye on Amid Industry Headwinds

Higher input costs and lower expected fertilizer use pose headwinds for the Zacks Fertilizers industry. NTR, ICL and IPI are set to tackle the challenges. 

ASH's Shares Rally 30% in 6 Months: What's Driving the Upside? 

Ashland's shares have gained 30.2% in six months as cost cuts, portfolio optimization and a $1-billion buyback support returns. 

Nutrien's Shares Rise 26% in a Year: What's Behind the Upside? 

NTR's shares have rallied 25.7% as firm fertilizer prices, record potash sales and cost discipline support earnings and free cash flow. 

Element Solutions Rallies 41% YTD: What's Driving the Stock? 

ESI's shares have rallied 40.8% YTD as stronger 2026 guidance, AI demand and cash generation bolster the outlook. 

Intrepid Potash, Inc. is a diversified mineral company, which engages in the delivery of potassium, magnesium, sulfur, salt, and water products essential for customer success in agriculture, animal feed, and the oil and gas industry. It operates through the following segments: Potash, Trio, and Oilfield Solutions. The company was founded by Hugh E. Harvey and Robert P. Jornayvaz in January 2000 and is headquartered in Denver, CO.

Intrepid Potash Inc

Intrepid Potash Stock Falls On Q4 Earnings Miss, Retail Turns Extremely Bearish

Equity

Neutral Sentiment

Shares of Intrepid Potash Inc. (IPI) fell by over 5.5% in Monday’s regular&nbsp;trading and extended the decline in the after-market session after the company’s fourth-quarter earnings missed Wall Street estimates.Intrepid Potash reported a loss of $0.11 per share, significantly&nbsp;worse than an estimated loss of $0.04 per share. The company posted a loss of $0.41 per share a year earlier.The Denver, Colorado-based fertilizer manufacturer reported revenue of $55.8 million, notably higher than a forecast of $50.35 million.Data from Stocktwits shows that the company missed earnings estimates in three of the past four quarters, while it has surpassed expectations in all of those quarters.“When I joined in December, my primary directive was clear: ensure we deliver on the previously established strategic priorities that will position Intrepid for long-term success,” said CEO Kevin Crutchfield.Despite the higher-than-expected loss per share, Crutchfield expressed optimism about the company’s prospects.“Over the past five months, key crops have rallied higher from their August lows, while potash prices have started to move higher due to the balanced global potash supply fundamentals and strong in-season demand during spring application.”Retail investors did not share the optimism, with the sentiment on Stocktwits cratering to enter the ‘extremely bearish’ (12/100) territory.<figure class="image"><img style="aspect-ratio:641/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/IPI_retail_sentiment_6e1832898f.jpg" alt="IPI retail sentiment.jpg" width="641" height="145"><figcaption>IPI sentiment and message volume March 4, 2025, as of 2 am ET | Source: Stocktwits</figcaption></figure>However, one user struck a different note, saying that tariffs could be helpful.<stembedurl>https://stocktwits.com/Smegma_Producer/message/606626191</stembedurl><a href="https://stocktwits.com/symbol/IPI">Intrepid’s stock</a> has gained over 12% year-to-date and nearly 17% over the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/okta-stock-rips-aftermarket-on-q4-earnings-beat/chejfNuRCJ">Okta Stock Rips Aftermarket On Q4 Beat, Better-Than-Expected Guidance: Retail Sentiment Soars</a>

Representative image of stock price falling.

Intrepid Potash reported a loss of $0.11 per share, significantly higher than an estimated loss of $0.04 per share. The company posted a loss of $0.41 per share during the same period from a year earlier.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.25	--	--	N/A
Q2 '26	$0.78	$0.56	-28.07%	MISSED
Q1 '26	$0.48	$0.62	28.68%	BEAT
Q4 '25	$0.33	$0.49	48.11%	BEAT
Q3 '25	$0.18	$0.11	-38.23%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

IPI Earnings

Upcoming Earnings: Q3 '26

Historical Earnings